Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Nexgenia Inc. See All Filings	D	2018-05-15 16:33:05 UTC
Amount To Be Raised $250,000 Associated Brokers / Dealers N/A CIK Number 0001623317 Filed Document 0001623317-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-05-15 16:33:05 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Debt
Nexgenia Inc. See All Filings	D	2017-04-05 16:19:45 UTC
Amount To Be Raised $1,900 Associated Brokers / Dealers N/A CIK Number 0001623317 Filed Document 0001168404-17-000006 Exclusions or Exemptions 506b Accepted Date 2017-04-05 16:19:45 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Nexgenia Inc. See All Filings	D	2016-08-19 10:47:36 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001623317 Filed Document 0001168404-16-000036 Exclusions or Exemptions 506b Accepted Date 2016-08-19 10:47:36 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Nexgenia Inc. See All Filings	D	2015-06-29 00:00:00 UTC
Amount To Be Raised $3,547,583 Associated Brokers / Dealers N/A CIK Number 0001623317 Filed Document 0001623317-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-06-29 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Nexgenia Inc. See All Filings	D	2014-10-26 00:00:00 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001623317 Filed Document 0001623317-14-000001 Exclusions or Exemptions 506b Accepted Date 2014-10-26 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Debt